In a new twist on Wednesday, a DEA judge ordered the agency to respond to allegations that it opposes President Joe Biden's ...
In 2025, cannabis faces major changes with federal reclassification, easing regulations, increasing research, and opening ...
Attorneys for a cannabis company and advocacy group that are set to testify in the Drug Enforcement Administration’s (DEA) marijuana rescheduling hearing process beginning this month say new evidence ...
Advocates accuse Drug Enforcement Administration of blocking the reclassification of cannabis as a Schedule III drug under the Controlled Substances Act.
Alexander Malyshev and Sarah Ganley of Carter Ledyard & Milburn LLP discuss what the cannabis sector can expect as 2025 ...
The Drug Enforcement Administration (DEA) is facing criticism after failing to release updated annual data on ...
Shares of cannabis stocks slumped after a company set to testify in the Drug Enforcement Administration's rescheduling hearings accused the agency of obstructing the rulemaking process.
The Merit Systems Protection Board needs to examine if the US government incorrectly denied a DEA agent a promotion for more ...
After serving the public for nearly 30 years and fighting to keep drugs off the streets, former DEA agent Keith Martin ...